Page last updated: 2024-08-21

digoxigenin and cyclin d1

digoxigenin has been researched along with cyclin d1 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ptaszyński, K	1
Bast, RC; Hoque, A; Lippman, SM; Liu, J; Lu, Z; Luo, RZ; Nishimoto, A; Sahin, AA; Wang, L; Yu, Y; Yuan, J	1
Dedes, KJ; Geyer, FC; Lacroix-Triki, M; Lambros, MB; Lopez-Garcia, MA; Natrajan, R; Reis-Filho, JS; Savage, K; Vatcheva, R; Wetterskog, D; Wilkerson, P	1

Reviews

1 review(s) available for digoxigenin and cyclin d1

Article	Year
[Molecular-genetic evaluation of translocation of bcl-2 gene and locus bcl-1 in selected lymphoproliferative changes]. Annales Academiae Medicae Stetinensis, 1992, Volume: 38 Topics: Blotting, Southern; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Cyclin D1; Digoxigenin; DNA, Neoplasm; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Translocation, Genetic	1992

Article

Year

[Molecular-genetic evaluation of translocation of bcl-2 gene and locus bcl-1 in selected lymphoproliferative changes].

Annales Academiae Medicae Stetinensis, 1992, Volume: 38

Topics: Blotting, Southern; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Cyclin D1; Digoxigenin; DNA, Neoplasm; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Translocation, Genetic

1992

Other Studies

2 other study(ies) available for digoxigenin and cyclin d1

Article	Year
Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-01, Volume: 9, Issue:10 Pt 1 Topics: Adult; Aged; Antibodies, Monoclonal; Blotting, Western; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytoplasm; Digoxigenin; Disease Progression; DNA, Complementary; Down-Regulation; Female; Genes, Tumor Suppressor; Humans; Immunohistochemistry; In Situ Hybridization; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; RNA; RNA, Messenger; Sensitivity and Specificity; Transfection	2003
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Breast cancer research and treatment, 2010, Volume: 124, Issue:3 Topics: Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Chromogenic Compounds; Chromosomes, Human, Pair 11; Cortactin; Cyclin D1; Digoxigenin; Disease-Free Survival; Female; Gene Amplification; Humans; Immunohistochemistry; In Situ Hybridization; Kaplan-Meier Estimate; London; Mastectomy; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies; Time Factors; Tissue Array Analysis; Treatment Outcome; Up-Regulation	2010

Article

Year

Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-01, Volume: 9, Issue:10 Pt 1

Topics: Adult; Aged; Antibodies, Monoclonal; Blotting, Western; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytoplasm; Digoxigenin; Disease Progression; DNA, Complementary; Down-Regulation; Female; Genes, Tumor Suppressor; Humans; Immunohistochemistry; In Situ Hybridization; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; RNA; RNA, Messenger; Sensitivity and Specificity; Transfection

2003

Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.

Breast cancer research and treatment, 2010, Volume: 124, Issue:3

Topics: Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Chromogenic Compounds; Chromosomes, Human, Pair 11; Cortactin; Cyclin D1; Digoxigenin; Disease-Free Survival; Female; Gene Amplification; Humans; Immunohistochemistry; In Situ Hybridization; Kaplan-Meier Estimate; London; Mastectomy; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies; Time Factors; Tissue Array Analysis; Treatment Outcome; Up-Regulation

2010